The Cardiovascular Cell Therapy Research Network , has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells for a clinical trial aimed at evaluating the safety and feasibility of treating patients with Left Ventricular Assist Devices .
http://ift.tt/1sKbZBD
http://ift.tt/1sKbZBD
No comments:
Post a Comment